PodLM
Home
API Keys
My Podcasts
Sign In
Toggle Sidebar
The Novartis Anthos Takeover: A Deep Dive
Sources
Novartis inks $925M Anthos takeover to buy back phase 3 clot-busting candidate
Update Podcast
Podcast Editor
Preview
Podcast.json
Preview
Audio
Podcast Information
Title
Description
Welcome to our podcast, where we explore the latest and most intriguing developments in the biotech and pharmaceutical industries. Today, we're diving into the recent $925 million acquisition of Anthos Therapeutics by Novartis. We'll break down the deal, the science behind abelacimab, and the implications for the future of anticoagulant treatments.
Topics
Remove
Remove
Remove
Remove
Remove
Remove
Remove
Remove
Remove
Remove
Add Topic
Roles
Scripts
